APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade Niacinamide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Grade Niacinamide Market Outlook and Growth Opportunities 2026

Report ID 17332813048 January 2026191 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade Niacinamide Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade Niacinamide Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade Niacinamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade Niacinamide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade Niacinamide Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade Niacinamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Grade Niacinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade Niacinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade Niacinamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Grade Niacinamide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Grade Niacinamide market include Zhejiang Lanbo Biotechnology, Lonza, Vertellus, Vanetta, Lasons India, Jubilant Life Sciences, DSM and Brother Enterprises, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade Niacinamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade Niacinamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade Niacinamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Niacinamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade Niacinamide Segment by Company

Zhejiang Lanbo Biotechnology

Lonza

Vertellus

Vanetta

Lasons India

Jubilant Life Sciences

DSM

Brother Enterprises

Pharmaceutical Grade Niacinamide Segment by Type

Liquid

Crystal

Powder

Pharmaceutical Grade Niacinamide Segment by Application

Pharmaceutical Industry

Daily Chemicals

Others

Pharmaceutical Grade Niacinamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Grade Niacinamide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Grade Niacinamide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Grade Niacinamide significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Grade Niacinamide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Niacinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Niacinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Niacinamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade Niacinamide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Niacinamide industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade Niacinamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Grade Niacinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Grade Niacinamide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade Niacinamide Industry Trends Table 2. Pharmaceutical Grade Niacinamide Industry Drivers Table 3. Pharmaceutical Grade Niacinamide Industry Opportunities and Challenges Table 4. Pharmaceutical Grade Niacinamide Industry Restraints Table 5. Global Pharmaceutical Grade Niacinamide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade Niacinamide Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Grade Niacinamide Sales Volume by Company (t) & (2021-2026) Table 8. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Grade Niacinamide Average Price (USD/t) of Company (2021-2026) Table 10. Global Pharmaceutical Grade Niacinamide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Grade Niacinamide Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Grade Niacinamide Company, Product Type & Application Table 13. Global Pharmaceutical Grade Niacinamide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade Niacinamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Liquid Table 18. Significant Companies of Crystal Table 19. Significant Companies of Powder Table 20. Global Pharmaceutical Grade Niacinamide Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Pharmaceutical Grade Niacinamide Sales Volume by Type (2021-2026) & (t) Table 22. Global Pharmaceutical Grade Niacinamide Sales Volume by Type (2027-2032) & (t) Table 23. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Type (2021-2026) Table 24. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Type (2027-2032) Table 25. Global Pharmaceutical Grade Niacinamide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Grade Niacinamide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Grade Niacinamide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Grade Niacinamide Sales Value Share by Type (2021-2026) Table 29. Global Pharmaceutical Grade Niacinamide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmaceutical Industry Table 31. Significant Companies of Daily Chemicals Table 32. Significant Companies of Others Table 33. Global Pharmaceutical Grade Niacinamide Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Pharmaceutical Grade Niacinamide Sales Volume by Application (2021-2026) & (t) Table 35. Global Pharmaceutical Grade Niacinamide Sales Volume by Application (2027-2032) & (t) Table 36. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Application (2021-2026) Table 37. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Application (2027-2032) Table 38. Global Pharmaceutical Grade Niacinamide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharmaceutical Grade Niacinamide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pharmaceutical Grade Niacinamide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Grade Niacinamide Sales Value Share by Application (2021-2026) Table 42. Global Pharmaceutical Grade Niacinamide Sales Value Share by Application (2027-2032) Table 43. Global Pharmaceutical Grade Niacinamide Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Pharmaceutical Grade Niacinamide Sales by Region (2021-2026) & (t) Table 45. Global Pharmaceutical Grade Niacinamide Sales Market Share by Region (2021-2026) Table 46. Global Pharmaceutical Grade Niacinamide Sales by Region (2027-2032) & (t) Table 47. Global Pharmaceutical Grade Niacinamide Sales Market Share by Region (2027-2032) Table 48. Global Pharmaceutical Grade Niacinamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pharmaceutical Grade Niacinamide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pharmaceutical Grade Niacinamide Sales Value Share by Region (2021-2026) Table 51. Global Pharmaceutical Grade Niacinamide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pharmaceutical Grade Niacinamide Sales Value Share by Region (2027-2032) Table 53. Global Pharmaceutical Grade Niacinamide Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Pharmaceutical Grade Niacinamide Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Pharmaceutical Grade Niacinamide Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Pharmaceutical Grade Niacinamide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pharmaceutical Grade Niacinamide Sales by Country (2021-2026) & (t) Table 58. Global Pharmaceutical Grade Niacinamide Sales Market Share by Country (2021-2026) Table 59. Global Pharmaceutical Grade Niacinamide Sales by Country (2027-2032) & (t) Table 60. Global Pharmaceutical Grade Niacinamide Sales Market Share by Country (2027-2032) Table 61. Global Pharmaceutical Grade Niacinamide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pharmaceutical Grade Niacinamide Sales Value Market Share by Country (2021-2026) Table 63. Global Pharmaceutical Grade Niacinamide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pharmaceutical Grade Niacinamide Sales Value Market Share by Country (2027-2032) Table 65. Zhejiang Lanbo Biotechnology Company Information Table 66. Zhejiang Lanbo Biotechnology Business Overview Table 67. Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacinamide Product Portfolio Table 69. Zhejiang Lanbo Biotechnology Recent Development Table 70. Lonza Company Information Table 71. Lonza Business Overview Table 72. Lonza Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Lonza Pharmaceutical Grade Niacinamide Product Portfolio Table 74. Lonza Recent Development Table 75. Vertellus Company Information Table 76. Vertellus Business Overview Table 77. Vertellus Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Vertellus Pharmaceutical Grade Niacinamide Product Portfolio Table 79. Vertellus Recent Development Table 80. Vanetta Company Information Table 81. Vanetta Business Overview Table 82. Vanetta Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Vanetta Pharmaceutical Grade Niacinamide Product Portfolio Table 84. Vanetta Recent Development Table 85. Lasons India Company Information Table 86. Lasons India Business Overview Table 87. Lasons India Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Lasons India Pharmaceutical Grade Niacinamide Product Portfolio Table 89. Lasons India Recent Development Table 90. Jubilant Life Sciences Company Information Table 91. Jubilant Life Sciences Business Overview Table 92. Jubilant Life Sciences Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Jubilant Life Sciences Pharmaceutical Grade Niacinamide Product Portfolio Table 94. Jubilant Life Sciences Recent Development Table 95. DSM Company Information Table 96. DSM Business Overview Table 97. DSM Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. DSM Pharmaceutical Grade Niacinamide Product Portfolio Table 99. DSM Recent Development Table 100. Brother Enterprises Company Information Table 101. Brother Enterprises Business Overview Table 102. Brother Enterprises Pharmaceutical Grade Niacinamide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Brother Enterprises Pharmaceutical Grade Niacinamide Product Portfolio Table 104. Brother Enterprises Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Pharmaceutical Grade Niacinamide Distributors List Table 108. Pharmaceutical Grade Niacinamide Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Pharmaceutical Grade Niacinamide Product Image Figure 2. Global Pharmaceutical Grade Niacinamide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade Niacinamide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade Niacinamide Sales (2021-2032) & (t) Figure 5. Global Pharmaceutical Grade Niacinamide Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Pharmaceutical Grade Niacinamide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Liquid Image Figure 10. Crystal Image Figure 11. Powder Image Figure 12. Global Pharmaceutical Grade Niacinamide Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Pharmaceutical Grade Niacinamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Type (2021-2032) Figure 15. Global Pharmaceutical Grade Niacinamide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmaceutical Grade Niacinamide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical Grade Niacinamide Sales Value Share by Type (2021-2032) Figure 18. Pharmaceutical Industry Image Figure 19. Daily Chemicals Image Figure 20. Others Image Figure 21. Global Pharmaceutical Grade Niacinamide Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Pharmaceutical Grade Niacinamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceutical Grade Niacinamide Sales Volume Share by Application (2021-2032) Figure 24. Global Pharmaceutical Grade Niacinamide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharmaceutical Grade Niacinamide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pharmaceutical Grade Niacinamide Sales Value Share by Application (2021-2032) Figure 27. Global Pharmaceutical Grade Niacinamide Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Pharmaceutical Grade Niacinamide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pharmaceutical Grade Niacinamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pharmaceutical Grade Niacinamide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pharmaceutical Grade Niacinamide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pharmaceutical Grade Niacinamide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pharmaceutical Grade Niacinamide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pharmaceutical Grade Niacinamide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pharmaceutical Grade Niacinamide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pharmaceutical Grade Niacinamide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pharmaceutical Grade Niacinamide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pharmaceutical Grade Niacinamide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pharmaceutical Grade Niacinamide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pharmaceutical Grade Niacinamide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pharmaceutical Grade Niacinamide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pharmaceutical Grade Niacinamide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Crystal
  • Powder
Applications
  • Pharmaceutical Industry
  • Daily Chemicals
  • Others
Companies covered
  • Zhejiang Lanbo Biotechnology
  • Lonza
  • Vertellus
  • Vanetta
  • Lasons India
  • Jubilant Life Sciences
  • DSM
  • Brother Enterprises

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade Niacinamide Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade Niacinamide Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Grade Niacinamide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Grade Niacinamide Market Dynamics
  1. 2.1 Pharmaceutical Grade Niacinamide Industry Trends
  2. 2.2 Pharmaceutical Grade Niacinamide Industry Drivers
  3. 2.3 Pharmaceutical Grade Niacinamide Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade Niacinamide Industry Restraints
3 Pharmaceutical Grade Niacinamide Market by Company
  1. 3.1 Global Pharmaceutical Grade Niacinamide Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Grade Niacinamide Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Grade Niacinamide Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Grade Niacinamide Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Grade Niacinamide Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Grade Niacinamide Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Grade Niacinamide Company Product Type and Application
  8. 3.8 Global Pharmaceutical Grade Niacinamide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Grade Niacinamide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Grade Niacinamide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Grade Niacinamide Market by Type
  1. 4.1 Pharmaceutical Grade Niacinamide Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Crystal
  4. 4.1.3 Powder
  5. 4.2 Global Pharmaceutical Grade Niacinamide Sales Volume by Type
  6. 4.2.1 Global Pharmaceutical Grade Niacinamide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pharmaceutical Grade Niacinamide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Pharmaceutical Grade Niacinamide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Pharmaceutical Grade Niacinamide Sales Value by Type
  10. 4.3.1 Global Pharmaceutical Grade Niacinamide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pharmaceutical Grade Niacinamide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Pharmaceutical Grade Niacinamide Sales Value Share by Type (2021-2032)
5 Pharmaceutical Grade Niacinamide Market by Application
  1. 5.1 Pharmaceutical Grade Niacinamide Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Daily Chemicals
  4. 5.1.3 Others
  5. 5.2 Global Pharmaceutical Grade Niacinamide Sales Volume by Application
  6. 5.2.1 Global Pharmaceutical Grade Niacinamide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Grade Niacinamide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Grade Niacinamide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pharmaceutical Grade Niacinamide Sales Value by Application
  10. 5.3.1 Global Pharmaceutical Grade Niacinamide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceutical Grade Niacinamide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pharmaceutical Grade Niacinamide Sales Value Share by Application (2021-2032)
6 Pharmaceutical Grade Niacinamide Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Grade Niacinamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade Niacinamide Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade Niacinamide Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Grade Niacinamide Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Grade Niacinamide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Grade Niacinamide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Grade Niacinamide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Grade Niacinamide Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Grade Niacinamide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Grade Niacinamide Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Grade Niacinamide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Grade Niacinamide Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Grade Niacinamide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Grade Niacinamide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Grade Niacinamide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Grade Niacinamide Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Grade Niacinamide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Grade Niacinamide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Grade Niacinamide Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Grade Niacinamide Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Grade Niacinamide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Grade Niacinamide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Grade Niacinamide Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Grade Niacinamide Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Grade Niacinamide Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Grade Niacinamide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Grade Niacinamide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Grade Niacinamide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Grade Niacinamide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Grade Niacinamide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Grade Niacinamide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Lanbo Biotechnology
  2. 8.1.1 Zhejiang Lanbo Biotechnology Company Information
  3. 8.1.2 Zhejiang Lanbo Biotechnology Business Overview
  4. 8.1.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacinamide Product Portfolio
  6. 8.1.5 Zhejiang Lanbo Biotechnology Recent Developments
  7. 8.2 Lonza
  8. 8.2.1 Lonza Company Information
  9. 8.2.2 Lonza Business Overview
  10. 8.2.3 Lonza Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lonza Pharmaceutical Grade Niacinamide Product Portfolio
  12. 8.2.5 Lonza Recent Developments
  13. 8.3 Vertellus
  14. 8.3.1 Vertellus Company Information
  15. 8.3.2 Vertellus Business Overview
  16. 8.3.3 Vertellus Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vertellus Pharmaceutical Grade Niacinamide Product Portfolio
  18. 8.3.5 Vertellus Recent Developments
  19. 8.4 Vanetta
  20. 8.4.1 Vanetta Company Information
  21. 8.4.2 Vanetta Business Overview
  22. 8.4.3 Vanetta Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vanetta Pharmaceutical Grade Niacinamide Product Portfolio
  24. 8.4.5 Vanetta Recent Developments
  25. 8.5 Lasons India
  26. 8.5.1 Lasons India Company Information
  27. 8.5.2 Lasons India Business Overview
  28. 8.5.3 Lasons India Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lasons India Pharmaceutical Grade Niacinamide Product Portfolio
  30. 8.5.5 Lasons India Recent Developments
  31. 8.6 Jubilant Life Sciences
  32. 8.6.1 Jubilant Life Sciences Company Information
  33. 8.6.2 Jubilant Life Sciences Business Overview
  34. 8.6.3 Jubilant Life Sciences Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Life Sciences Pharmaceutical Grade Niacinamide Product Portfolio
  36. 8.6.5 Jubilant Life Sciences Recent Developments
  37. 8.7 DSM
  38. 8.7.1 DSM Company Information
  39. 8.7.2 DSM Business Overview
  40. 8.7.3 DSM Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DSM Pharmaceutical Grade Niacinamide Product Portfolio
  42. 8.7.5 DSM Recent Developments
  43. 8.8 Brother Enterprises
  44. 8.8.1 Brother Enterprises Company Information
  45. 8.8.2 Brother Enterprises Business Overview
  46. 8.8.3 Brother Enterprises Pharmaceutical Grade Niacinamide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Brother Enterprises Pharmaceutical Grade Niacinamide Product Portfolio
  48. 8.8.5 Brother Enterprises Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade Niacinamide Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade Niacinamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade Niacinamide Sales Mode & Process
  6. 9.2 Pharmaceutical Grade Niacinamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade Niacinamide Distributors
  9. 9.2.3 Pharmaceutical Grade Niacinamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst